DrugPatentWatch Database Preview
Exela Pharma Scs Llc Company Profile
What is the competitive landscape for EXELA PHARMA SCS LLC, and what generic alternatives to EXELA PHARMA SCS LLC drugs are available?
EXELA PHARMA SCS LLC has eight approved drugs.
There is one US patent protecting EXELA PHARMA SCS LLC drugs.
Summary for Exela Pharma Scs Llc
| US Patents: | 1 |
| Tradenames: | 8 |
| Ingredients: | 8 |
| NDAs: | 8 |
Drugs and US Patents for Exela Pharma Scs Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma Scs Llc | NIPRIDE RTU IN SODIUM CHLORIDE 0.9% | sodium nitroprusside | SOLUTION;INTRAVENOUS | 209387-003 | Jul 13, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Exela Pharma Scs Llc | NIPRIDE RTU IN SODIUM CHLORIDE 0.9% | sodium nitroprusside | SOLUTION;INTRAVENOUS | 209387-002 | Dec 7, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Exela Pharma Scs Llc | GLYRX-PF | glycopyrrolate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 210997-002 | Jul 11, 2018 | RX | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
